Kidneys and Genito-Urinary System - Urinary Incontinence Drug Pipeline Report - Study the Top 20 Companies in Early and Late Stage of Development
Posted on: Thursday, 13 September 2007, 12:00 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c68368) has announced the addition of "Kidneys and Genito-Urinary System - Urinary Incontinence Drug Pipeline Report" to their offering.
"Kidneys and Genito-Urinary System - Urinary Incontinence Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of urinary incontinence drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
Keep track of your competitors and partners by better understanding their product pipeline.
Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
Maintain a critical competitive advantage.
Content Outline:
Urinary Incontinence Pipeline Overview
% of Projects (By Phase of Development)
No. of Projects by Phase of Development
Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
Company Overview - Pipeline Projects
Legend
Top 20 companies in late stage Urinary Incontinence Projects
Top 20 companies in early stage Urinary Incontinence Projects
Full Pipeline View
Phase II Pipeline View
For more information visit http://www.researchandmarkets.com/reports/c68368
Source: Business Wire
Related Articles
- New License Agreement with University of Colorado Gives Viral Genetics, Inc., Right to Develop Cancer Therapies
- Lignol Signs Cellulosic Ethanol Project Development Agreement With Suncor
- Major Solar Power Project Developers and Financiers to Gather at Industry's Annual Deal-Making Event
- Minco Silver Wins Project Development Award
- Major Wind Power Project Developers and Financiers to Gather at Industry's Annual Deal-Making Event
- GE Business Unit Grows in India With Stake in Investment Arm of KSK, Leading Indian Power Project Developer
- BrightSource Energy Names SVP For Project Development
- Entire Spectrum of Business Models to Be Presented at Unique Solar Project Development Tutorial Scheduled for November for San Diego
- AGTC and JDRF Announce Partnership to Develop Gene Therapy for Diabetic Eye Disease
- BigLever Software Helps Bridge the Communication Gap Between Product Marketing and Software Development to Streamline Product Line Evolution
 |
 |
User Comments (0)
RSS Feeds